Presence of GHRH mRNA in Human Pituitary Somatotrophinomas and Its Relationship to in vitro Effect of a GHRH-antagonist on GH Secretion and cAMP Production

Pituitary

Volumn 1, Issue 1, 1998, Pages 7-12

  Adams, Eric Frank ^a,c   Law, Helen ^b   Buchfelder, Michael ^a   Fahlbusch, Rudolf ^a   Lightman, Stafford ^b   Levy, Andrew ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Autocrine; GHRH; mRNA; Pituitary; Somatotrophinoma

Indexed keywords

CYCLIC AMP; DRUG DERIVATIVE; GROWTH HORMONE RELEASING FACTOR; HUMAN GROWTH HORMONE; MESSENGER RNA; RNA; SERMORELIN;

ADENOMA; ARTICLE; BIOSYNTHESIS; CELL CULTURE; DNA PROBE; DRUG ANTAGONISM; GENETICS; HUMAN; HYPOPHYSIS TUMOR; IN SITU HYBRIDIZATION; METABOLISM; NUCLEOTIDE SEQUENCE; SECRETION;

ADENOMA; BASE SEQUENCE; CYCLIC AMP; DNA PROBES; GROWTH HORMONE-RELEASING HORMONE; HUMAN GROWTH HORMONE; HUMANS; IN SITU HYBRIDIZATION; PITUITARY NEOPLASMS; RNA, MESSENGER; RNA, NEOPLASM; SERMORELIN; TUMOR CELLS, CULTURED;

EID: 0032034463     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009917306289     Document Type: Article

References (27)

1. Harris GW. Neural Control of the Pituitary Gland. London: Edward Arnold Publishers, 1955.
2. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R. Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 1973;179:77-79.
3. Rivier J, Spiess J, Thorner M, Vale W. Characterisation of a growth hormone releasing factor from a human pancreatic islet tumour. Nature 1982;300:276-278.
4. Guilleman R, Brazeau P, Bohlen PE, Esch F, Ling N, Wehrenberg W. Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 1982;218:585-587.
5. Joubert (Bression) D, Benlot C, Lagoguey A, Garnier P, Brabdi AM, Gautron JP, Legrand JC, Peillon F. Normal and growth hormone (GH) -secreting adenomatous human pituitaries release somatostatin and GH-releasing hormone. J Clin Endocrinol Metab 1989;68:572-577.
6. Levy A, Lightman SL. Growth hormone-releasing hormone transcripts in human pituitary adenomas. J Clin Endocrinol Metab 1992;74:1474-1476.
7. Levy A, Lightman SL. Relationship between somatostatin and growth hormone messenger ribonucleic acid in human pituitary adenomas: An in-situ hybridization histochemistry study. Clin Endocrinol 1990;32:661-668.
8. Wakabayashi I, Inokuchi K, Hasegawa O, Sugihara H, Minami S. Expression of growth hormone (GH)-releasing factor gene in GH-producing pituitary adenoma. J Clin Endocrinol Metab 1992;74:357-361.
9. Le Dafniet M, Blumberg-Tick J, Gozlan H, Barret A, Joubert (Bression) D, Peillon F. Altered balance between thyrotropin-releasing hormone and dopamine in prolactinomas and other pituitary tumors compared to normal pituitaries. J Clin Endocrinol Metab 1989;69:267-271.
10. Joubert D, Le Dafniet M, Pagesy P, Li Y, Benlot C, Peillon F. Neuropeptides as autocrine or paracrine factors of anterior pituitary secretion. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary Adenomas: New Trends in Basic and Clinical Research. Elsevier Science Publishers, 1991:55-64.
11. Peillon F, Joubert D, Pagesy P, Li JY, Brandi AM, Le Dafniet M. Receptor and neuropeptide studies in nonsecreting pituitary adenomas. In: Faglia G, Beck-Peccoz P, Ambrosi B, Travaglini P, Spada A, eds. Pituitary Adenomas: New Trends in Basic and Clinical Research. Elsevier Science Publishers, 1991:55-64.
12. 2 as a GRF antagonist on membranes. Endocrinology 1985;117:1759-1764.
13. Adams EF, Lei T, Buchfelder M, Petersen B, Fahlbusch R. Biochemical characteristics of human pituitary somatotropinomas with and without gsp mutations: In vitro cell culture studies. J Clin Endocrinol Metab 1995;80:2077-2081.
14. Adams EF, Lei T, Buchfelder M, Bowers CY, Fahlbusch R. Protein kinase C-dependent growth hormone releasing peptides stimulate cyclic adenosine 3′,5′-monophosphate production by human pituitary somatotropinomas expressing gsp oncogenes: Evidence for cross-talk between transduction pathways. Mol Endocrinol 1996;10:432-438.
15. Young WSIII, Bonner TI, Brann MR. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 1986;83:9827-9831.
16. s and stimulate adenyl cyclase in human pituitary tumours. Nature 1989;340:692-696.
17. Adams EF, Brockmeier S, Friedman E, Roth M, Buchfelder M, Fahlbusch R. Clinical and biochemical characteristics of acromegalic patients harboring gsp-positive and gsp-negative pituitary tumors. Neurosurgery 1993;33:198-203.
18. Ueta Y, Levy A, Powell M, Lightman SL, Yoshimasa K, Yokata A, Yamashita H. Neuronal nitric oxide synthase gene expression in human pituitary tumours: A possible association with somatotroph adenomas and growth hormone-releasing hormone gene expression. Clin Endocrinol 1997 (in press).
19. Levy A, Lightman SL. Local production of hypothalamic trophic peptides in human pituitary tumours. Clin Chem Enz Comm 1992;5:265-273.
20. Levy A, Powell M, Lightman SL. Colocalization of corticotrophin-releasing hormone and oxytocin transcripts in human pituitary adenomas. Endo J 1993;1:117-122.
21. Bennett PA, Levy A, Sophokleous S, Robinson ICAF, Lightman SL. Hypothalamic growth hormone receptor gene expression in the rat: Effects of altered growth hormone status. J Endocrinol 1995;147:225-234.
22. Adams EF, Buchfelder M, Lei T, Petersen B, Fahlbusch R. Molecular biology of growth-hormone-secreting human pituitary tumours: Biochemical consequences and potential clinical significance. In: Fahlbusch R, Bock WJ, Brock M, Buchfelder M, Klinger M, eds. Modern Neurosurgery of Meningiomas and Pituitary Adenomas. Springer Publishers, 1996:7-10.
23. Billestrup N, Swanson LW, Vale W Growth hormone-releasing factor stimulates proliferation of somatotrophs in vitro. Proc Natl Acad Sci USA 1986;83:6854-6857.
24. Mayo KE, Hammer RE, Swanson LW, Brinster RL, Rosenfeld MG, Evans RM. Dramatic pituitary hyperplasia in transgenic mice expressing a growth hormone-releasing factor gene. Mol Endocrinol 1985;2:606-612.
25. Burton FH, Hasel KW, Bloom FE, Sutcliffe JG. Pituitary hyperplasia and gigantism in mice caused by a cholera toxin transgene. Nature 1991;350:74-77.
26. 2 on growth hormone (GH)-releasing factor-stimulated 3′,5′-monphosphate accumulation in rat primary pituitary cell culture. Endocrinology 1989;124:2791-2798.
27. Wu D, Chen C, Katoh K, Zhang J, Clarke IJ. The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist. J Endocrinol 1994;140:R9-R13.